Hangzhou Converd Co., Ltd.

This is an early-stage study to test the safety of a new cancer treatment called hV01. The treatment uses a modified virus designed to infect and kill cancer cells while also boosting the immune system. The study will enroll 24 adults with advanced solid tumors that have not resp…